{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:05:30Z","timestamp":1765728330498},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:00:00Z","timestamp":1182211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2007,9,10]]},"DOI":"10.1007\/s00198-007-0406-0","type":"journal-article","created":{"date-parts":[[2007,6,18]],"date-time":"2007-06-18T16:49:49Z","timestamp":1182185389000},"page":"1421-1427","source":"Crossref","is-referenced-by-count":28,"title":["Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world"],"prefix":"10.1007","volume":"18","author":[{"given":"H.","family":"Ideguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,19]]},"reference":[{"key":"406_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14656566.1.2.225","volume":"1","author":"MR McClung","year":"2000","unstructured":"McClung MR (2000) Bisphosphonates in osteoporosis: recent clinical experience. Expert Opin Pharmacother 1:225\u2013238","journal-title":"Expert Opin Pharmacother"},{"key":"406_CR2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP et al (2004) Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"406_CR3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1345\/aph.1G534","volume":"40","author":"DT Gold","year":"2006","unstructured":"Gold DT, Alexander IM, Ettinger MP (2006) How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy. Ann Pharmacother 40:1143\u20131150","journal-title":"Ann Pharmacother"},{"key":"406_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","volume":"48","author":"JS McCombs","year":"2004","unstructured":"McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48:271\u2013287","journal-title":"Maturitas"},{"key":"406_CR5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00198-003-1431-2","volume":"14","author":"A Papaioannou","year":"2003","unstructured":"Papaioannou A, Ioannidis G, Adachi JD, Sebaldt RJ, Ferko N, Puglia M et al (2003) Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 14:808\u2013813","journal-title":"Osteoporos Int"},{"key":"406_CR6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.amjmed.2005.12.019","volume":"119","author":"RD Emkey","year":"2006","unstructured":"Emkey RD, Ettinger M (2006) Improving compliance and persistence with bisphosphonate therapy for osteoporosis. Am J Med 119:S18\u2013S24","journal-title":"Am J Med"},{"key":"406_CR7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","volume":"17","author":"D Weycker","year":"2006","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17:1645\u20131652","journal-title":"Osteoporos Int"},{"key":"406_CR8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00198-006-0136-8","volume":"17","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG (2006) Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. Osteoporos Int 17:1268\u20131274","journal-title":"Osteoporos Int"},{"key":"406_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","volume":"115","author":"AN Tosteson","year":"2003","unstructured":"Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209\u2013216","journal-title":"Am J Med"},{"key":"406_CR10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00198-006-0073-6","volume":"17","author":"M Rossini","year":"2006","unstructured":"Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L et al (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914\u2013921","journal-title":"Osteoporos Int"},{"key":"406_CR11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2005.12.018","volume":"119","author":"JA Cramer","year":"2006","unstructured":"Cramer JA, Silverman S (2006) Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem. Am J Med 119:S12\u2013S17","journal-title":"Am J Med"},{"key":"406_CR12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4065\/77.10.1031","volume":"77","author":"B Cryer","year":"2002","unstructured":"Cryer B, Bauer DC (2002) Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc 77:1031\u20131043","journal-title":"Mayo Clin Proc"},{"key":"406_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","volume":"14","author":"B Hamilton","year":"2003","unstructured":"Hamilton B, McCoy K, Taggart H (2003) Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 14:259\u2013262","journal-title":"Osteoporos Int"},{"key":"406_CR14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00198-004-1818-8","volume":"16","author":"CS Pickney","year":"2005","unstructured":"Pickney CS, Arnason JA (2005) Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 16:1156\u20131160","journal-title":"Osteoporos Int"},{"key":"406_CR15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","volume":"52","author":"JR Curtis","year":"2005","unstructured":"Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485\u20132494","journal-title":"Arthritis Rheum"},{"key":"406_CR16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2006.01.002","volume":"28","author":"FJ Penning-van Beest","year":"2006","unstructured":"Penning-van Beest FJ, Goettsch WG, Erkens JA, Herings RM (2006) Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Clin Ther 28:236\u2013242","journal-title":"Clin Ther"},{"key":"406_CR17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570\u2013578","journal-title":"Endocr Rev"},{"key":"406_CR18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s001980200135","volume":"13","author":"M Fukunaga","year":"2002","unstructured":"Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H et al (2002) A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporos Int 13:971\u2013979","journal-title":"Osteoporos Int"},{"key":"406_CR19","first-page":"50","volume":"18","author":"T Mersfelder","year":"1999","unstructured":"Mersfelder T, Armitstead JA, Ivey MF, Cedars M (1999) A medication use evaluation of alendronate: compliance with administration guidelines. Pharm Pract Manag Q 18:50\u201358","journal-title":"Pharm Pract Manag Q"},{"key":"406_CR20","first-page":"252","volume":"11","author":"I Tanaka","year":"2003","unstructured":"Tanaka I, Hayakawa K, Oshima H (2003) Tolerance of alendronate in patients with osteoporosis. Osteoporosis Jpn 11:252\u2013255","journal-title":"Osteoporosis Jpn"},{"key":"406_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/089686080602600206","volume":"26","author":"H Naito","year":"2006","unstructured":"Naito H (2006) The Japanese health-care system and reimbursement for dialysis. Perit Dial Int 26:155\u2013161","journal-title":"Perit Dial Int"},{"key":"406_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00534-005-1046-4","volume":"13","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Takada T, Kawarada Y, Hirata K, Mayumi T, Sekimoto M et al (2006) Health insurance system and payments provided to patients for the management of severe acute pancreatitis in Japan. J Hepatobiliary Pancreat Surg 13:7\u20139","journal-title":"J Hepatobiliary Pancreat Surg"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-007-0406-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0406-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T04:29:08Z","timestamp":1587616148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-007-0406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,19]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,10]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1007\/s00198-007-0406-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,19]]}}}